The visual abstract for SONAR
SONAR: Is there a Signal in the Noise?
The First NephJC Google Hangout
We are interested in finding innovative ways to share the collective wisdom of the nephrology community. The Twitter discussions have been excellent so far. Our next experiment is a Google Hangout, which is a video chat. The idea is that we will present a new journal article on alternating Tuesdays. Then on the off Tuesday we will broadcast a Google Hangout which will summarize the previous week's Twitter Chat and introduce the next week's journal club article. This will provide a tick-tock rhythm to NephJC.
We are new to Google Hangouts so we will be experimenting with various formats. For the first one we will have one of the article's authors, Vlado Perkovic join Joel Topf, Paul Phelan and Hiremath Swapnil on the Hangout. We will take audience questions during the hangout.
Each hangout will be recorded and added to commentary on the article.
NephJC #2 - Atrasentan: Analytics and Transcript
I fixed up the wikipedia article on atrasentan
The new journal club for Tuesday is a study of atrasentan for diabetic kidney disease. When I wrote introduction post I went to wikipedia and learned that atrasentan had been in trials as an antineoplastic agent. I went to the Twitter and asked if anyone was using it.
He then gave me the keys to the kingdom by showing me where to search NCI site for trials. Bingo.
I was Quickly able to find the failed phase 3 trial and updated wikipedia.